Petr Widimský
Petr Widimský publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, on topics such as Acute Myocardial Infarction Research, Antiplatelet Therapy and Cardiovascular Diseases and Coronary Interventions and Diagnostics.
- World rank
- #533,245 of 7,710,434 ranked researchers
- Rank in Czechia
- #809 of 39,303
- Works
- 61
- Citations
- 16k
- Citations per work
- 269.2
What does Petr Widimský research?
Petr Widimský's work is mostly in Medicine (86%), Engineering (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5386.3%
- Medicine5386.3%
- Everything else710.9%
- Physical Sciences22.8%
- Engineering22.8%
- 1Cardiology and Cardiovascular Medicine55% of their works
- 2Surgery20% of their works
- 3Radiology, Nuclear Medicine and Imaging7% of their works
- 4Internal Medicine3% of their works
- 5Biomedical Engineering3% of their works
- 6Pulmonary and Respiratory Medicine2% of their works
Research topics
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Interventions and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Mechanical Circulatory Support Devices
- Cardiac Valve Diseases and Treatments
- Venous Thromboembolism Diagnosis and Management
Which keywords describe Petr Widimský's research?
The keywords of their largest research topics: Percutaneous Coronary Intervention, Guidelines, Myocardial Infarction, Acute Coronary Syndromes, ST-Segment Elevation, Aspirin, Clopidogrel and Coronary Stents.
- Transcatheter Aortic-Valve Replacement
- Left Ventricular Assist Device
- Antithrombotic Therapy
- Cardiac Imaging
- Anticoagulant Therapy
- Coronary Stents
- Aspirin
- Acute Coronary Syndromes
- Guidelines
- Percutaneous Coronary Intervention
- Myocardial Infarction
- ST-Segment Elevation
- Clopidogrel
- Myocardial Revascularization
- Atrial Fibrillation
- Coronary Artery Disease
- Extracorporeal Membrane Oxygenation
- Surgical Aortic-Valve Replacement
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Percutaneous Coronary Intervention563 topics
- Guidelines472 topics
- Myocardial Infarction442 topics
- Acute Coronary Syndromes321 topic
- ST-Segment Elevation321 topic
- Aspirin281 topic
- Clopidogrel281 topic
- Coronary Stents231 topic
- Myocardial Revascularization231 topic
- Anticoagulant Therapy151 topic
- Atrial Fibrillation151 topic
- Cardiac Imaging121 topic
- Coronary Artery Disease121 topic
- Antithrombotic Therapy51 topic
- Extracorporeal Membrane Oxygenation51 topic
- Left Ventricular Assist Device51 topic
- Surgical Aortic-Valve Replacement51 topic
- Transcatheter Aortic-Valve Replacement51 topic
- Venous Thromboembolism51 topic
Where does Petr Widimský work?
Petr Widimský's main affiliation in the publication record is Charles University, Czechia.
How many publications and citations does Petr Widimský have?
OpenAlex counts 61 works and 16,420 citations for Petr Widimský, an h-index of 25, ranking #533,245 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Petr Widimský
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Petr Widimský. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.